These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 529462)

  • 1. [The protective effects of corticosteroid agent on the side effects of intravenous cholecystography (author's transl)].
    Ohshima T; Mio A; Tsukiyama I
    Rinsho Hoshasen; 1979 Aug; 24(8):831-7. PubMed ID: 529462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of side effects in intravenous cholangiocystography. 1].
    Preuss HJ
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1985-90. PubMed ID: 5144066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].
    Schmerwitz W; Rösch E
    Rontgenblatter; 1977 Feb; 30(2):71-8. PubMed ID: 576505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of differentiated registration of contrast medium side-reaction (author's transl)].
    Barke R; Bolck M
    Radiol Diagn (Berl); 1974; 15(3):361-6. PubMed ID: 4425129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
    Schmerwitz W
    Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does oral and intravenous "refill" cholegraphy have nephrotoxic effects?].
    Bor K; Elek S; Elekes I; Polgári I; Csákány G
    Orv Hetil; 1984 Apr; 125(14):815-9. PubMed ID: 6709344
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quality of roentgenological visualization and tolerance of various intravenous cholegraphic contrast media (author's transl)].
    Tischendorf P
    Rontgenblatter; 1980 Nov; 33(11):581-7. PubMed ID: 7003680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sources of error in the in-vitro diagnosis of thyroid function (author's transl)].
    Seegelken K; Nies D
    Dtsch Med Wochenschr; 1973 Nov; 98(46):2197-200. PubMed ID: 4127946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute kidney failure following intravenous cholecystography].
    Meier W; Hoffmann H
    Munch Med Wochenschr; 1971 Apr; 113(17):652-5. PubMed ID: 5108311
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anuria following oral cholecystography].
    Wirth F; Kenderesi P; Hajducki I
    Orv Hetil; 1970 Jul; 111(30):1760-3. PubMed ID: 5457700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the problem of hepatotoxic tropic contrast substances during cholangiocholecystography (author's transl)].
    Bruna J; Bártek R
    Cesk Radiol; 1975 Mar; 29(2):108-14. PubMed ID: 1132053
    [No Abstract]   [Full Text] [Related]  

  • 13. Bilivistan, a new contrast medium for I. V. cholegraphy.
    Egeblad M
    Dan Med Bull; 1966 May; 13(2):36-40. PubMed ID: 5328496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Minor complications encountered in oral cholecystography].
    Djian A; Annonier C; Prouveur P
    J Radiol Electrol Med Nucl; 1975; 56(8-9):613-4. PubMed ID: 1185710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies regarding a new contrast medium for demonstrating the patency of bile ducts (author's transl)].
    Krueger P; Fries HH
    Rontgenblatter; 1976 Nov; 29(11):540-3. PubMed ID: 1013630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comment on the paper: "Death after intravenous administration of Visotrast" in Z.ärztl. Fortbild. 71, (1977),1,p.40-2].
    Barke R
    Z Arztl Fortbild (Jena); 1977 Aug; 71(15):741-3. PubMed ID: 919604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Adverse effects of x-ray contrast media].
    Viehweger G
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2623. PubMed ID: 4434862
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral cholecystographic agents and floating gallstones.
    Gooding GA
    J Clin Ultrasound; 1982 Sep; 10(7):A28-30. PubMed ID: 6815226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications and risks of cholanigocholecystography].
    Crespi Porro R
    Minerva Med; 1968 Sep; 59(74):3910-8. PubMed ID: 5679587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complications of oral cholecystography. Results of an survey by the French Radiological Society].
    Nahum H; Levesoue M
    J Radiol Electrol Med Nucl; 1975; 56(8-9):614-5. PubMed ID: 1185711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.